Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

This Award Notice opportunity from Texas was posted on September 23, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Apheresis Serv for Cell Therapy Support

Awarded
P-2026-0729State & Local

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 621991
Grant
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Solicitation # RFA-CA-28-004
The National Cancer Institute (NCI) has issued a Notice of Funding Opportunity (RFA-CA-28-004) for a limited competition to support the continuation of two critical biospecimen banking resources: the National Clinical Trials Network (NCTN) Biobanks and the Early-Phase and Experimental Clinical Trials (EET) Biobank. The primary objective is to maintain national resources for the collection, processing, storage, and distribution of clinically annotated human biospecimens to enable translational cancer research, biomarker development, and the investigation of drug response and resistance mechanisms. The NCI intends to fund approximately six awards with a total program funding of $19 million for fiscal year 2027, with a maximum direct cost limit of $3.0 million per year and a requested project period of six years. Applications are evaluated based on scientific and technical merit through the NIH peer-review system, focusing on significance, environment, and the likelihood of the project to exert a sustained influence on the research field. Eligible organizations must maintain active SAM and eRA Commons registrations and provide specific documentation, including the current scale of operation, accomplishments, and standard operating procedures. Awardees are required to implement robust quality assurance programs, adhere to Federal Human Subjects Regulations under 45 CFR 46, and follow strict cybersecurity incident reporting protocols, including notifying the HHS within 48 hours of discovery. There is no set-aside status specified for this opportunity.
National Institutes Of Health

POSTED

about 1 month ago

DEADLINE

in 3 months
NAICS: 621991
Grant
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Solicitation # RFA-CA-28-004
The National Cancer Institute is issuing a limited competition Notice of Funding Opportunity, solicitation RFA-CA-28-004, to support the continuation of two critical biospecimen banking resources. These resources include the National Clinical Trials Network Biobanks, which support the NCTN and the Community Oncology Research Program, and the Early-Phase and Experimental Clinical Trials Biospecimen Bank, which supports the ETCTN and other early-phase experimental trials. The primary objective is to maintain national infrastructure for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens to enable translational cancer research, biomarker development, and the study of drug response and resistance. Eligible organizations must submit applications by February 12, 2027, to be considered for funding. All submissions will undergo a standard NIH peer-review process, and only meritorious applications will be selected. These banks are essential for linking biospecimens to clinical outcome data from large multi-site trials and supporting the development of novel cancer therapies through pharmacokinetic and pharmacodynamic analyses.
National Cancer Institute

POSTED

about 1 month ago

DEADLINE

in 3 months

AI Contract Overview

Show more

The University of Texas Medical Branch at Galveston has entered into a contract with Carter Bloodcare for the provision of third party apheresis services to support cell therapy. This agreement, identified by solicitation number P-2026-0729, is valued at 1,900,000.00 dollars and spans a duration of three years. The contract was posted on September 23, 2026, with a response deadline extending to September 22, 2029. The primary objective of this partnership is to outsource cell collection and manufacturing processes to ensure the timely delivery of cell therapy support. This strategic decision was made to avoid potential operational delays that would be associated with the construction and implementation of an internal laboratory. The procurement process has been executive certified for compliance, and the arrangement is managed under the state organization of Texas.

General Info

Contract Value

$1,900,000

Place of Performance

Not specified

Set-Aside

NONE

Award Issued Date

Contract End Date

September 22, 2029

Documents

1
PDF, Low priorityjustification-and-authorization
Low

Read the document

Every page of every file, in your free workspace.

Read the document

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

This one is closed. Find the next one like it.

Open contracts like this one, right now:

  • National Transplant Registry Registration ServicesOpen now, due in 6 days
  • Q999--INTENT TO SOLE SOURCE United Network for Organ SharingOpen now, due in 6 days
See open contracts like this

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyThe University of Texas Medical Branch at Galveston
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Get AI-powered intelligence on the opportunities still open

Every solicitation package arrives shredded into a compliance breakdown and matched to your past performance, with incumbent history and alerts on amendments and award.

Miguel
Hillary
Keith Deutsch
Christine

Join 900+ contractors already using CLEATUS